Precision Medicine Test for Psoriasis Biologics
In only five minutes and a penny sized patch, Mindera Health technology captures thousands of RNA transcripts.
We enable scalable collection and analysis of individualized genetic information to provide actionable data-driven decisions for patients, providers, and payers.
We are committed to providing our community with the latest information on how we are making an impact in precision medicine.
Visit our news tab today to learn more!
Provider status with Medi-Cal will allow Mindera Health to provide its proprietary Mind.Px test to predict biologic class response in plaque psoriasis to the over 15 million Medi-Cal Beneficiaries. San Diego, CA, Aug 19, 2024 (GLOBE NEWSWIRE) — Mindera Health, developer of Mind.Px™, the first realization of precision
Request a demo zoom call today to help your patient’s receive the right biologic treatment
© Copyright 2024, Mindera Health I ISO 13485:2016 CERTIFIED PRIVACY POLICY I TERMS OF USE..
